Connection

Andrew Kraft to Neoplasm Metastasis

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Neoplasm Metastasis.
Andrew Kraft
Connection Strength
0.108
Neoplasm Metastasis
  1. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999 Jan 01; 85(1):178-87.
    View in: PubMed
    Score: 0.037
  2. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clin Cancer Res. 2018 01 01; 24(1):169-180.
    View in: PubMed
    Score: 0.034
  3. A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas. Cancer. 2005 Apr 01; 103(7):1431-8.
    View in: PubMed
    Score: 0.014
  4. [Staging and study procedure in small-cell bronchial carcinoma]. Dtsch Med Wochenschr. 1984 Jun 08; 109(23):910-2.
    View in: PubMed
    Score: 0.013
  5. Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. Clin Cancer Res. 2000 Nov; 6(11):4205-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.